View in EDS PDF Full Text

Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors-is it time for a paradigm shift?

Saved in:
Bibliographic Details
Title: Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors-is it time for a paradigm shift?
Authors: Chatzidionysiou K; Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden. aikaterini.chatzidionysiou@ki.se.; Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden. aikaterini.chatzidionysiou@ki.se., Liapi M; Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden., Tsakonas G; Thoracic Oncology Center, Karolinska University Hospital, Stockholm, Sweden.; Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden., Gunnarsson I; Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden., Catrina A; Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden.
Source: Clinical rheumatology [Clin Rheumatol] 2021 May; Vol. 40 (5), pp. 1687-1695. Date of Electronic Publication: 2020 Sep 28.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 8211469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-9949 (Electronic) Linking ISSN: 07703198 NLM ISO Abbreviation: Clin Rheumatol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32989505
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors-is it time for a paradigm shift?
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chatzidionysiou+K%22">Chatzidionysiou K</searchLink>; Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden. aikaterini.chatzidionysiou@ki.se.; Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden. aikaterini.chatzidionysiou@ki.se.<br /><searchLink fieldCode="AU" term="%22Liapi+M%22">Liapi M</searchLink>; Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Tsakonas+G%22">Tsakonas G</searchLink>; Thoracic Oncology Center, Karolinska University Hospital, Stockholm, Sweden.; Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Gunnarsson+I%22">Gunnarsson I</searchLink>; Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Catrina+A%22">Catrina A</searchLink>; Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228211469%22">Clinical rheumatology</searchLink> [Clin Rheumatol] 2021 May; Vol. 40 (5), pp. 1687-1695. <i>Date of Electronic Publication: </i>2020 Sep 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8211469 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1434-9949 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2207703198%22">07703198 </searchLink><i>NLM ISO Abbreviation: </i>Clin Rheumatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32989505
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10067-020-05420-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1687
    Titles:
      – TitleFull: Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors-is it time for a paradigm shift?
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chatzidionysiou K
      – PersonEntity:
          Name:
            NameFull: Liapi M
      – PersonEntity:
          Name:
            NameFull: Tsakonas G
      – PersonEntity:
          Name:
            NameFull: Gunnarsson I
      – PersonEntity:
          Name:
            NameFull: Catrina A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2021 May
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1434-9949
          Numbering:
            – Type: volume
              Value: 40
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Clinical rheumatology
              Type: main
ResultId 1